This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Institut Curie, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2010-2014.
Company Filing History:
2 out of 5,383 
2 out of 161 
1 out of 8,801 
Years Active: 2010-2014
Title: The Innovative Contributions of Andreï Popov
Introduction
Andreï Popov is a notable inventor based in Voreppe, France. He has made significant contributions to the field of pharmaceuticals, particularly through his work on isoquinolones and their applications in medicine. With a total of 2 patents, his innovations are paving the way for advancements in cancer treatment.
Latest Patents
Popov's latest patents include the use of isoquinolones for preparing drugs, which encompasses novel isoquinolones and their synthesis methods. This invention focuses on isoquinolone derivatives that are utilized in the treatment of pathological angiogenesis, specifically targeting cancer. Another significant patent involves dibenzo[c,h][1,5]naphthyridines and their use as DNA probes. This invention details novel dibenzo[c,h][1,5]naphthyridine compounds and methods for marking DNA, showcasing their potential in genetic research.
Career Highlights
Throughout his career, Andreï Popov has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Institut Curie. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and development capabilities.
Collaborations
Some of his notable coworkers include Jean-Claude Florent and Aurélie Juhem. Their collaborative efforts have contributed to the success of his innovative projects and patents.
Conclusion
Andreï Popov's work exemplifies the impact of innovation in the pharmaceutical industry. His patents not only advance scientific knowledge but also hold promise for improving cancer treatment methodologies.